This course is co-organised by ERS and the ESTS

A multidisciplinary update on potentially operable lung cancer

Organisers : Gilbert Massard & Bogdan Grigoriu

This course, co-organised by ERS and the European Society of Thoracic Surgeons (ESTS) provides an update on the screening, management and treatment options for patients with potentially operable lung cancer. The course format alternates between state of the art lectures, case-based teaching and interactive multidisciplinary workshops.

An application for CME accreditation will made to the European Accreditation Council for Continuing Medical Education (EACCME). The number of credits granted corresponds to attendance during the onsite course. Please note that you need to sign the register of attendance each day to ensure that you receive the CME credits.

Target audience

The course fits well into the continuig professional development of thoracic surgeons, pulmonary physicians, radiation oncologists and medical oncologists. It may also appeal to trainee-specialists in these 4 fields.


  • Screening
  • Classification of lung cancer
  • New diagnostic tools
  • Early stage lung cancer
  • Alternative treatments
  • Surgery for early stage small cell lung cancer
  • Perioperative treatments
  • Surgery for advanced disease
  • Complex situations
  • Innovative treatments
  • Patient safety and quality of life
Practical Information
€ 700 ERS/ESTS members € 800 Non-ERS Members € 1000 Industry
(ERS Members & non-Members)

The Member fee is applicable to active ERS and ESTS members at the time of registration. The fee includes two nights’ accommodation.

Register before the early-bird deadline on 25 January, 2019 to benefit from a €50 discount on registration fees.

Cancellation policy

Travel Info

Registering for someone else ? Contact Sandy Borlat

Register now

There are no bursaries available for this course.